The past President of ⁦European Atherosclerosis Society⁩ ⁦Lale Tokgozoglu⁩ supports the stepwise approach in #ACS patients as M. Blaha supported the unneeded #CAC at #ESCCongress 😎 ⁦Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦⁩ ⁦Maciej Banach⁩ ⁦@AngoulvantD⁩ ⁦@cpcannon⁩

Esperion Announces CLEAR Cardiovascular Outcomes Trial of NEXLETOL® (bempedoic acid) Meets Primary Endpoint. Looking forwards to results at ACC ⁦Steve Nicholls⁩ ⁦National Lipid Association⁩ ⁦ASPC⁩ ⁦Cardiometabolic Health Congress⁩ ⁦ esperion.com/news-releases/…

Esperion Inc. Announces CLEAR Cardiovascular Outcomes Trial of NEXLETOL® (bempedoic acid) Meets Primary Endpoint ow.ly/hOav50LXxPU

Congratulations to James de Lemos, alum of TIMI Study Group and Brigham & Women's CV Fellows, on being named Chief of Cardiology at @UTSWNews. James is a terrific choice to lead UTSW into the future. Looking forward to continued collaborations!

Rigorous #FOURIER event adjudication explained - misguided & uninformed attacks refuted! timi.org/bmjopenrespons…

“We have complete confidence in the FOURIER results adjudicated by the TIMI CEC.  The paper by Erviti et al. is flawed in design and execution and, in our opinion, a gross disservice to the medical literature, cardiovascular health care providers, and patients.”

Obicetrapibip + ezetimibe added to high intensity statin leads to 59% reduction in LDL-C. CETPi still alive.

What are the top 10 research lessons learned from TIMI in 2022? Find out at timi.org/top-timi-lesso… Ben Scirica Erin Bohula Robert Giugliano Stephen Wiviott Michelle O'Donoghue Brian Bergmark David Berg Nicholas Marston André Zimerman Filipe A Moura, MD, PhD Prakriti Gaba Sid M. Patel

Another extremely productive year of science for TIMI Study Group. See the output below and link to top lessons. #CardioTwitter

Grateful to have had the opportunity to work on this important study. Thanks to Dr. Sabatine, Michelle O'Donoghue, Stephen Wiviott and Robert Giugliano for their invaluable mentorship!

Can cardiac biomarkers help identify T2D patients at higher risk of atherosclerotic events and who benefit more from dapagliflozin? Find out in our paper ja.ma/3II1c6v via JAMA Cardiology part of JAMA Network Stephen Wiviott TIMI Study Group Kardiologie MedUni Wien Forschung MedUni Wien

Free claim Wiktoria Klin-Lee @lamyth_burna Ciru Jenny Thegreatscalper💎 ARIYEN RAY Irene N Knight WIZO ehsan k Anjie 🌷Rossie🌷 @FONDADONOVAN7

biggest drop Brian O'Neill HeisnbergTrader Babatunde ajiboye CryptoSpaceGhost Jonas Dovydas Pirate King Kiba 🐕 Jason Evans CuanFi_8 VikKup Crypto warld Panagiotis MALLIS Cavid

Announcing our new redesigned online platform for TIMI calculators! This interactive tool has several flexible functionalities, detailed descriptions, and allows users to upload data and calculate TIMI risk scores for several individuals. timi.org/timi-calculato…

#AHA24 #ZODIAC : despite a positive trend of the tool, the primary outcome isn’t reached, advocating the #upfront strategy using #HIS and #Ezetimibe BEFORE discharge in #ACS patients

VESALIUS-CV #ACC26 LBCT results out now in JAMA Nicholas Marston Erin Bohula Robert Giugliano jamanetwork.com/journals/jama/…

We are deeply saddened to have lost our founding chairman and the father of modern academic cardiology, Dr. Eugene Braunwald, who founded the TIMI Study Group in 1984, and with that vision profoundly shaped the practice of cardiovascular medicine across the world.